Therefore, the aim of this review of published data is to compare the magnitude and duration of the effects on HR induced by various GLP-1 RAs, both in healthy individuals and in those with T2DM, utilizing individual 24-h HR measurements from clinical trials, including head-to-head comparison data
Overall, our meta-analysis underscores the value of GLP-1RAs as a multifaceted therapeutic option, particularly in PCOS patients with obesity and IR
The database can be freely accessed at The FDA publishes the FAERS datasets quarterly (every 3 months)
More is not better with GLP-1 medications
Increasing fibre intake and staying hydrated can help maintain regular bowel movements
Pricing Implications and Market Dynamics The cost-of-goods advantage of small-molecule manufacturing does not automatically translate into lower retail pricing, as pharmaceutical pricing is determined by factors including development costs, market competition, patent protection, payer negotiations, and value-based pricing frameworks